Dr. Abhishek Marballi

Claim this profile

MultiCare Institute for Research & Innovation

Studies Colorectal Cancer
1 reported clinical trial
4 drugs studied

More about Abhishek Marballi

Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Abhishek Marballi has experience with
  • Atezolizumab
  • GRT-C901
  • GRT-R902
  • Ipilimumab
Breakdown of trials Abhishek Marballi has run

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Abhishek Marballi specialize in?
Abhishek Marballi focuses on Colorectal Cancer and other conditions. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Abhishek Marballi currently recruiting for clinical trials?
No, Abhishek Marballi is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Abhishek Marballi has studied deeply?
Yes, Abhishek Marballi has studied treatments such as Atezolizumab, GRT-C901, GRT-R902.
What is the best way to schedule an appointment with Abhishek Marballi?
Apply for one of the trials that Abhishek Marballi is conducting.
What is the office address of Abhishek Marballi?
The office of Abhishek Marballi is located at: MultiCare Institute for Research & Innovation, Tacoma, Washington 98405 United States. This is the address for their practice at the MultiCare Institute for Research & Innovation.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.